Gastroesophageal Reflux in Idiopathic Pulmonary Fibrosis: More than a Gut Feeling?

Respiration

Volumn 91, Issue 1, 2016, Pages 1-2

  Wuyts, Wim A ^a   Collard, Harold R ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; HUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT PARAMETERS; EMOTION; LUNG FIBROSIS;

EMOTIONS; GASTROESOPHAGEAL REFLUX; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; PULMONARY FIBROSIS;

EID: 84955750132     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000443183     Document Type: Note

References (14)

1. Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ: Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968-1977.
2. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW et al.: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083-2092
3. Richeldi, L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR et al.: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-2082.
4. Raghu G, Rochwerg B, Zhang Y, Cuello Garcia CA, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, Johkoh T, Martinez FJ, Myers J, Protzko SL, Richeldi L, Rind D, Selman M, Theodore A, Wells AU, Hoogsteden H, Schünemann HJ; on behalf of the ATS, ERS, JRS, and ALAT: An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 2015;192:e3-e19.
5. Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G; IPFnet Investigators: Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med 2013;1:369-376.
6. Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, King TE Jr, Collard HR: Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;184:1390-1394.
7. Tcherakian C, Cottin V, Brillet PY, Freynet O, Naggara N, Carton Z, Cordier JF, Brauner M, Valeyre D, Nunes H: Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease. Thorax 2011;66:226-231.
8. Lee JS, Song JW, Wolters PJ, Elicker BM, King TE Jr, Kim DS, Collard HR: Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J 2012;39:352-358.
9. Ibrahim WH: Helicobacter pylori eradication in the management of idiopathic pulmonary fibrosis. Eur Respir J 2007;30:395-396.
10. Kreuter M, Kirsten D, Bahmer T, Penzel R, Claussen M, Ehlers-Tenenbaum S, Muley T, Palmowski K, Eichinger M, Leider M, Herth FJF, Rabe KF, Bittmann I, Warth A: Screening for Helicobacter pylori in idiopathic pulmonary fibrosis lung biopsies. Respiration 2016; 91:3-8.
11. Lee JS, Collard HR, Raghu G, Sweet MP, Hays SR, Campos GM, Golden JA, King TE Jr: Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med 2010;123:304-311.
12. Wuyts WA, Agostini C, Antoniou KM, Bouros D, Chambers RC, Cottin V, Egan JJ, Lambrecht BN, Lories R, Parfrey H, Prasse A, Robalo-Cordeiro C, Verbeken E, Verschakelen JA, Wells AU, Verleden GM. The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J 2013;41:1207-1218.
13. Prasse A, Binder H, Jäger B, Schupp J, Bargagli E, Vuga L, Lynn H, Herazo-Mayo J, Rottoli P, Wuyts W, Kaminski N: BAL signature predictive of mortality in idiopathic pulmonary fibrosis is highly enriched for airway basal cell genes. ICLAF 2014, North America, August 2014. http://www.iclaf.com/conference/index.php/2014/ICLAF/paper/view/48
14. McDonough JE, Verleden S, Vercauteren I, Verschakelen JA, Verbeken E, Decramer M, Verleden GM, Vanaudenaerde BM, Hogg J, Wuyts W: 3-D reconstruction of small airways in IPF. Am J Respir Crit Care Med 2015;191:A5575.